ITMR News and Press, Itamar Medical Ltd. From 02/04/21

CAESAREA, Israel, Feb. 04, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Thursday, February 4th by Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), please note that the contact information was incorrect. The corrected release follows: Itamar Medical Ltd. ( ...

Itamar Medical (ITMR) commenced a proposed public offering of ADSs; each ADS representing 30 ordinary shares of the company.ADSs to be sold in the offering will be offered by the company and one of its shareholders, Viola Growth 2 A.V.The company and the selling shareholder intend to gra...

CAESAREA, Israel, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (“Itamar Medical” or the “Company”) (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the di...

CAESAREA, Israel, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today announced the appointment of Scott P. Se...

Itamar Medical (ITMR) +2.6% premarket, acquires technology and assets of Spry Health for an undisclosed cash amount.Spry, based in the San Francisco Bay area, develops a wrist based medical grade remote patient monitoring ((RPM)) solutions.The acquisition of FDA-cleared, wrist-...

Enables Itamar to leverage Spry’s existing FDA-cleared technology to bring to market the first device for continuous remote patient monitoring (RPM) of sleep apnea Adds the capability to monitor the longer-term accumulated disease burden of sleep apnea to complement the sin...

Itamar Medical (ITMR) +2% premarket, expects Q4 revenue in the range of $12.5M-$12.8M, reflecting growth of 28%-31% and above consensus of $11.71M; WatchPAT revenue of $12M-$12.3M, representing growth of 32%-35%; U.S. WatchPAT revenue of $10M-$10.3M, representing growth of 36% ...

- 2020 Fourth Quarter Revenues Expected to Increase More Than 28% to $12.5-$12.8 million - - 2020 Fiscal Year Revenues Expected to Increase Approximately 31% to $40.8-$41.1 million - CAESAREA, Israel, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (N...

CAESAREA, Israel, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today announced that Health Care Service Corpo...

CAESAREA, Israel, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today commented on the recent release of the 2...